Deciphering allogeneic antibody response against native and denatured HLA epitopes in organ transplantation

European Journal of Immunology

Volumn 45, Issue 7, 2015, Pages 2111-2121

  Visentin, Jonathan ^a,b   Guidicelli, Gwendaline ^a   Moreau, Jean François ^a,b   Lee, Jar How ^c   Taupin, Jean Luc ^a,b  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c One Lambda   (United States)

Author keywords

Anti denatured HLA antibodies; HLA antibodies; HLA epitopes; Luminex single antigen bead assay

Indexed keywords

EPITOPE; HLA ANTIBODY; HLA ANTIGEN; ANTIBODY; HLA ANTIGEN CLASS 1;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME DENATURATION; EPITOPE MAPPING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOREACTIVITY; LYMPHOCYTE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; ALLOGRAFT; GENETICS; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGY;

ALLOGRAFTS; ANTIBODIES; EPITOPES; FLOW CYTOMETRY; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; ORGAN TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 84935711465     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445340     Document Type: Article

References (29)

1. Dunn, T. B., Noreen, H., Gillingham, K., Maurer, D., Ozturk, O. G., Pruett, T. L., Bray, R. A. et al., Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am. J. Transplant 2011. 11: 2132-2143.
2. Lefaucheur, C., Loupy, A., Hill, G. S., Andrade, J., Nochy, D., Antoine, C., Gautreau, C. et al., Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J. Am. Soc.Nephrol. 2010. 21: 1398-1406.
3. Couzi, L., Araujo, C., Guidicelli, G., Bachelet, T., Moreau, K., Morel, D., Robert, G. et al., Interpretation of positive flow cytometriccrossmatch in the era of the single-antigen bead assay. Transplantation 2011. 91: 527-535.
4. Wiebe, C., Gibson, I. W., Blydt-Hansen, T. D., Karpinski, M., Ho, J., Storsley, L. J., Goldberg, A. et al., Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am. J. Transplant 2012. 12: 1157-1167.
5. Hidalgo, L. G., Campbell, P. M., Sis, B., Einecke, G., Mengel, M., Chang, J., Sellares, J. et al., De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am. J. Transplant 2009. 9: 2532-2541.
6. Lachmann, N., Terasaki, P. I., Budde, K., Liefeldt, L., Kahl, A., Reinke, P., Pratschke, J. et al., Anti-human leukocyte antigen and donor-specific antibodies detected by luminexposttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009. 87: 1505-1513.
7. Pei, R., Lee, J., Chen, T., Rojo, S. and Terasaki, P. I., Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum.Immunol. 1999. 60: 1293-1302.
8. Pei, R., Lee, J. H., Shih, N. J., Chen, M. and Terasaki, P. I., Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003.75: 43-49.
9. El-Awar, N., Terasaki, P. I., Cai, J., Deng, C. T., Ozawa, M. and Nguyen, A., Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens. Clin.Transpl. 2007: 175-194.
10. Duquesnoy, R. J., A structurally based approach to determine HLA compatibility at the humoral immune level. Hum.Immunol. 2006. 67: 847-862.
11. Duquesnoy, R. J. and Marrari, M., Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens. Tissue Antigens 2009.74: 117-133.
12. Morales-Buenrostro, L. E., Terasaki, P. I., Marino-Vazquez, L. A., Lee, J. H., El-Awar, N. and Alberu, J., "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008.86: 1111-1115.
13. El-Awar, N., Terasaki, P. I., Nguyen, A., Sasaki, N., Morales-Buenrostro, L. E., Saji, H., Maruya, E. et al., Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. Hum. Immunol. 2009. 70: 844-853.
14. Visentin, J., Guidicelli, G., Bachelet, T., Jacquelinet, C., Audry, B., Nong, T., Dubois, V. et al., Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocation. Transplantation 2014. 98: 738-744.
15. Schnabl, E., Stockinger, H., Majdic, O., Gaugitsch, H., Lindley, I. J., Maurer, D., Hajek-Rosenmayr, A. et al., Activated human T lymphocytes express MHC class I heavy chains not associated with beta 2-microglobulin. J. Exp. Med. 1990. 171: 1431-1442.
16. Pickl, W. F., Holter, W., Stockl, J., Majdic, O. and Knapp, W., Expression of beta 2-microglobulin-free HLA class I alpha-chains on activated T cells requires internalization of HLA class I heterodimers. Immunology 1996. 88: 104-109.
17. Bodnar, A., Bacso, Z., Jenei, A., Jovin, T. M., Edidin, M., Damjanovich, S. and Matko, J., Class I HLA oligomerization at the surface of B cells is controlled by exogenous beta(2)-microglobulin: implications in activation of cytotoxic T lymphocytes. Int. Immunol. 2003. 15: 331-339.
18. Perosa, F., Luccarelli, G., Prete, M., Favoino, E., Ferrone, S. and Dammacco, F., Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide. J.Immunol. 2003.171: 1918-1926.
19. Ladasky, J. J., Shum, B. P., Canavez, F., Seuanez, H. N. and Parham, P., Residue 3 of beta2-microglobulin affects binding of class I MHC molecules by the W6/32 antibody. Immunogenetics 1999.49: 312-320.
20. Mulder, A., Eijsink, C., Kester, M. G., Franke, M. E., Kardol, M. J., Heemskerk, M. H., van Kooten, C. et al., Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies. J. Immunol. 2005. 175: 5950-5957.
21. Cai, J., Terasaki, P. I., Anderson, N., Lachmann, N. and Schonemann, C., Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure. Transplantation 2009. 88: 226-230.
22. Otten, H. G., Verhaar, M. C., Borst, H. P., van Eck, M., van Ginkel, W. G., Hene, R. J. and van Zuilen, A. D., The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation. Clin. Exp.Immunol. 2013. 173: 536-543.
23. Jacob, E. K., De Goey, S. R. and Gandhi, M. J., Positive virtual crossmatch with negative flow crossmatch results in two cases. Transpl. Immunol. 2011. 25: 77-81.
24. Nikaein, A., El-Awar, N., Hunt, J., Rosenthal, E. J., Eichhorn, E., Hall, S., Boehrer, J. et al., Clinically irrelevant circulating human leukocyte antigen antibodies in the presence of ventricular assist devices. J. Heart Lung Transplant 2012. 31: 443-447.
25. Pereira, S., Perkins, S., Lee, J. H., Shumway, W., LeFor, W., Lopez-Cepero, M., Wong, C. et al., Donor-specific antibody against denatured HLA-A1: clinically nonsignificant? Hum. Immunol. 2011. 72: 492-498.
26. Montgomery, R. A., Lonze, B. E., King, K. E., Kraus, E. S., Kucirka, L. M., Locke, J. E., Warren, D. S. et al., Desensitization in HLA-incompatible kidney recipients and survival. N. Engl. J. Med. 2011. 365: 318-326.
27. Tait, B. D., Susal, C., Gebel, H. M., Nickerson, P. W., Zachary, A. A., Claas, F. H., Reed, E. F. et al., Consensus guidelines on the testing and clinical management issues associated with HLA and Non-HLA antibodies in transplantation. Transplantation 2013. 95: 19-47.
28. Hogue, C. W., Cn3D: a new generation of three-dimensional molecular structure viewer. Trends Biochem. Sci. 1997. 22: 314-316.
29. Sun, Y., Liu, J., Yang, M., Gao, F., Zhou, J., Kitamura, Y., Gao, B. et al., Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses. J. Gen. Virol. 2010. 91: 919-930.